Tentt

ABS Bio to Acquire Cureline in Add-On Deal

Announced
HealthcareCaliforniaAdd-on

Deal Overview

ABS Bio has announced the acquisition of Cureline as an add-on deal. The stated goal is to broaden access to biospecimens and streamline execution across an end-to-end workflow.

Cureline will be incorporated into ABS Bio’s broader operating model to improve how biospecimens are accessed and how projects are delivered from start to finish.

Key Details

Transaction
ABS Bio acquires Cureline
Deal Size
Over $100M

Source

Read full article on news.google.com

via Google News - add-on · January 6, 2026

Powered by Tentt

Source healthcare deals in California for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call